Table 2 Univariate and multivariate analysis of elafin-positive cells in luminal A-like breast cancer patients
A: Univariate analysis of clinicopatholoigal variable in luminal A patients (n = 343) | ||||
|---|---|---|---|---|
Factors | Â | Elafin Negative (n = 185) | Elafin Positive (n = 158) | P value |
Age at diagnosis, year | Â | Â | Â | 0.8 |
Mean | Â | 56.7 | 56.4 | Â |
Median (range) |  | 55 (26–84) | 57 (29–87) |  |
Stage | Â | Â | Â | <0.0001 |
I | Â | 81 (44.0) | 38 (24.2) | Â |
IIA | Â | 79 (42.9) | 83 (52.9) | Â |
IIB | Â | 24 (13.0) | 36 (22.9) | Â |
Unknown | Â | 1 | 1 | Â |
Grade | Â | Â | Â | 0.001 |
I | Â | 31 (18.3) | 15 (10.3) | Â |
II | Â | 122 (72.2) | 96 (65.7) | Â |
III | Â | 16 (9.5) | 35 (24.0) | Â |
Unknown | Â | 16 | 12 | Â |
Recurrence | Â | Â | Â | <0.0001 |
No | Â | 158 (86.3) | 98 (62.4) | Â |
Yes | Â | 25 (13.7) | 59(37.6) | Â |
Unknown | Â | 2 | 1 | Â |
B: Multivariate of clinicopathologic variables’ influence on RFS in luminal A patients (n = 343) | ||||
Factor | HR | Se | P | 95% CI |
Age | 0.97 | 0.01 | <0.0001 | 0.95-0.98 |
Elafin positive | 3 | 0.73 | <0.0001 | 1.87-4.82 |